고지방식이와 스트렙토조토신으로 유도한 당뇨마우스에서 Chlorogenic Acid의 혈당강하 및 항산화 효과

국문 초록 (Abstract)

본 연구는 고지방식이와 STZ으로 유도한 제2형 당뇨마우스에게 CA를 급여하였을 때 체내 당대사와 항산화방어계에 미치는 영향을 규명하고자 하였다. 4주령 ICR 마우스를 고지방식이(전체 열량의 37% 지방)를 4주간 급여하여 인슐린 저항성을 유발한 후 STZ(100 ㎎/㎏ body weight)을 일회 복강주사 하였다. 7일 후 공복 시 혈당이 14 m㏖/ℓ(250 ㎎/㎗)인 마우스만을 사용하여 난괴법으로 당뇨대조군, 0.02% CA군, 0.05% CA군으로 나누어 6주간 사육하였다. 실험 6주 동안 당뇨대조군에 비하여 두 CA 급여 수준은 혈당을 효과적으로 낮추었으며 내당능과 인슐린내성을 개선하였다. 또한 혈장 중의 렙틴 함량은 CA 급여 시 당뇨대조군에 비하여 높았으나 인슐린과 C-peptide 함량 및 체중에는 영향을 미치지 않았다. CA 급여는 당뇨대조군에 비하여 간조직의 GK 활성을 높였고 G6Pase 활성은 낮춘 반면, PEPCK 활성에는 영향을 미치지 않았다. 간조직 중의 SOD와 CAT 활성은 CA 급여군에서 당뇨대조군에 비하여 유의적으로 높았으나, GSH-Px 활성과 적혈구의 항산화 효소 활성은 실험군간 유의적인 변화가 없었다. 두 수준의 CA 급여는 간조직과 적혈구 중의 지질과산화물 함량을 당뇨대조군에 비하여 유의적으로 낮추었다. 이와 같이 CA는 간조직에서 당 이용을 높이는 반면, 당 신생을 억제함으로써 혈당저하에 효과적이었으며 항산화방어계를 활성화하여 지질과산화물 생성을 개선하는데 효과적인 것으로 나타났다.

다국어 초록 (Multilingual Abstract)

This study investigated dose-response effects of chlorogenic acid (CA) on glucose metabolism and the antioxidant system in streptozotocin (STZ)-induced diabetic mice with a high-fat diet (HFD). Male ICR mice were fed with a HFD (37% calories from fat) for 4 weeks prior to intraperitoneal injection with STZ (100 ㎎/㎏ body weight). Diabetic mice were supplemented with two doses of CA (0.02% and 0.05%, wt/wt) for 6 weeks. Both doses of CA significantly improved fasting blood glucose level, glucose tolerance and insulin tolerance without any changes in plasma insulin and C-peptide levels. Plasma leptin concentration was significantly higher in the CA-supplemented groups than in the diabetic control group. Both doses of CA significantly increased hepatic glucokinase activity and decreased glucose-6-phosphatase activity compared to the diabetic control group. The ratio of glucokinase/glucose-6-phosphatase was dose-independently higher in CA-supplemented mice than in diabetic control mice. CA supplementation dose-independently elevated superoxide dismutase and catalase activities, whereas it lowered lipid peroxide levels compared to the diabetic control mice in the liver and erythrocyte. These results suggest that low-dose CA may be used as a hypoglycemic agent in a high-fat diet and STZ-induced diabetic mice.

목차 (Table of Contents)

• Abstract
• 서론
• 재료 및 방법
• 결과 및 고찰
• 요약
• 감사의 글
• 문헌

참고문헌 (Reference)

1 이재혁, "제2형 당뇨병 환자에서 Rosiglitazone의 치료 반응에 대한 예측인자로서 혈청 렙틴 농도의 유용성에 대한 평가" 대한당뇨병학회 27 (27): 420-432, 2003

2 Thom E, "The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people" 35 : 900-908, 2007

3 Sakurai T, "Superoxide production from nonenzymatically glycated protein" 236 : 406-410, 1988

4 McCord JM, "Superoxide dismutase: an enzymetic function for erythrocuprein (Hemocuprein)" 244 : 2049-6055, 1969

5 Paglia ED, "Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase" 70 : 158-169, 1967

6 Newgard CB, "Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat" 258 : 8046-8052, 1983

7 Rice-Evans CA, "Structure antioxidant activity relationship of flavonoids and phenolic acids" 20 : 933-956, 1996

8 Iynedjian PB, "Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats" 263 : 740-744, 1988

9 Hulcher FH, "Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A" 14 : 625-631, 1973

10 Baynes JW, "Role of oxidative stress in development of complications in diabetes" 40 : 405-412, 1991

11 American Institute of Nutrition, "Report of the American Institute of Nutrition ad hoc Committee of Standard for Nutritional Studies" 107 : 1340-1348, 1977

12 Schwarz PE, "Report from the congress of the American Diabetes Association (ADA)" 113 : 475-479, 2005

13 Mohamed-Ali V, "Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus" 14 : 376-380, 1997

14 Campfield LA, "Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural network" 269 : 546-549, 1995

15 Wolff SP, "Protein glycation and oxidative stress in diabetes mellitus and aging" 10 : 339-352, 1991

16 Herling AW, "Prolonged blood glucose reduction inmrp-2 deficient rats (GY/TR(-)) by the glucose-6-phosphatetranslocase inhibitors 3025" 1569 : 105-110, 2002

17 Zhang Y, "Positional cloning of the mouse obese gene and its human homologue" 372 : 425-432, 1994

18 Ong KW, "Polyphenols- rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats" 133 : 598-607, 2011

19 Parker JC, "Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase" 47 : 1630-1636, 1998

20 DeFronzo RA, "Pathogenesis of NIDDM. A balanced overview" 15 : 318-368, 1992

21 Jay D, "Oxidative stress and diabetic cardiovascular complications" 40 : 183-192, 2006

22 Cosio FG, "New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation" 67 : 2415-2421, 2005

23 Ministry of Health and Welfare, "Korea Health Statistics2010: Korea National Health and Nutrition ExaminationSurveys" Ministry of Health and Welfare 2010

24 Marklund S, "Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase" 47 : 469-474, 1974

25 Bentle LA, "Interaction of anions and divalent metal ions with phosphoenolpyruvate carboxykinase" 251 : 2916-2921, 1976

26 Rodriguez de Sotillo DV, "Insulin receptor exon 11+/- is expressed in zucker (fa/fa) rats and chlorogenic acid modifies their plasma insulin and liver protein and DNA" 17 : 63-71, 2006

27 Li BH, "Inhibitory activity of chlorogenic acid on enzymes involved in the fatty acid synthesis in animals and bacteria" 58 : 39-46, 2006

28 Reed MJ, "In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery" 1 : 75-86, 1999

29 Nicasio P, "Hypoglycemic effect and chlorogenic acid content in two Cecropia species" 19 : 661-664, 2005

30 Ceriello A, "Hyperglycaemia: the bridge between nonenzymatic glycation and oxidative stress in the pathogenesis of diabetic complications" 12 : 42-46, 1999

31 Mullarkey CJ, "Free radical generation by glycation products: a mechanism for accelerated atherogenesis in diabetes" 173 : 932-939, 1990

32 Davidson AL, "Factors underlying significant underestimation of glucokinase activity in crude liver extract: physiological implications of higher cellular activity" 253 : 156-167, 1987

33 Munoz MC, "Effects of tungstate, a new potential oral antidiabetic agents in Zucker diabetic fatty rats" 50 : 131-139, 2001

34 Lv L, "Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin" 24 : 219-224, 2010

35 Postic C, "Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β-cellspecific gene knock-outs using Cre recombinase" 274 : 305-315, 1999

36 Sang Youl Rhee, "Diabcare Asia 2001-Korea : Country Report on Outcome Data and Analysis" 대한내과학회 20 (20): 48-54, 2005

37 Alegre M, "Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction" 173 : 185-189, 1988

38 Karthikesan K, "Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide- induced diabetic rats" 29 : 23-30, 2010

39 Bassoli BK, "Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia" 26 : 320-328, 2008

40 Rodriguez de Sotillo DV, "Chlorogenic acid modifies plasma and liver concentrations of cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats" 13 : 717-726, 2000

41 Cho AS, "Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-inducedobese mice" 48 : 937-943, 2010

42 Hemmerle H, "Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase" 40 : 137-145, 1997

43 Tarladgis BG, "Chemistry of the 2-thiobarbituric acid test for determination of oxidative rancidity in foods" 15 : 602-607, 1964

44 MeLennan SV, "Changes in hepatic glutathione metabolism in diabetes" 40 : 344-348, 1991

45 Deisseroth A, "Catalase: physical and chemical properties, mechanism of catalysis, and physiological role" 50 : 319-375, 1970

46 Aebi H, "Catalase in vitro" 105 : 121-126, 1988

47 Dong-Ju Kim, "Beneficial Effect of Chungkukjang on Regulating Blood Glucose and Pancreatic β-Cell Functions in C75BL/KsJ-db/db Mice" 한국식품영양과학회 11 (11): 215-223, 2008

48 Ohkawa H, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction" 95 : 351-358, 1979

49 Chen JH, "Antioxidant activities of caffeic acid and its related hydroxycinnamic acid compounds" 45 : 2374-2378, 1997

50 Jung UJ, "Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice" 318 : 476-483, 2006

51 Bradford MM, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding" 72 : 248-254, 1976

52 김태헌, "12주간의 운동프로그램이 제2형 당뇨병 환자의 Superoxide dismutase와 Malondialdehyde에 미치는 영향" 한국코칭능력개발원 7 (7): 217-224, 2005